Neogenomics (NEO) Gains from Sales and Divestitures (2012 - 2017)
Neogenomics (NEO) reported Gains from Sales and Divestitures of $182744.0 for Q4 2017, up 452.38% on a YoY basis from $33083.0 in Q4 2016, and up 452.38% quarter-over-quarter from $33083.0 in Q4 2016.
Neogenomics (NEO) Gains from Sales and Divestitures (2012 - 2017) Analysis & Trends
Neogenomics has reported Gains from Sales and Divestitures for 6 years, with the latest figure at $182744.0 in Q4 2017.
- For the quarter ending Q4 2017, Gains from Sales and Divestitures rose 452.38% year-over-year to $182744.0; the trailing twelve-month figure through Dec 2017 stood at $182744.0 (up 452.38% YoY), and the FY2017 full-year result was $182744.0, up 452.38% from the prior year.
- Gains from Sales and Divestitures for Q4 2017 stood at $182744.0, up from $33083.0 in the prior quarter.
- The five-year high for Gains from Sales and Divestitures was $182744.0 in Q4 2017, with the low at $12820.0 in Q4 2015.
- Historically, Gains from Sales and Divestitures has averaged $55754.4 across 5 years, with a median of $32000.0 in 2013.
- Annual changes were most pronounced in 2014 — Gains from Sales and Divestitures slumped 43.36% — and 2017, when it surged 452.38%.
- Neogenomics' Gains from Sales and Divestitures stood at $32000.0 in 2013, then tumbled by 43.36% to $18125.0 in 2014, then decreased by 29.27% to $12820.0 in 2015, then jumped by 158.06% to $33083.0 in 2016, then surged by 452.38% to $182744.0 in 2017.
- The last three Gains from Sales and Divestitures figures came in at $182744.0 (Q4 2017), $33083.0 (Q4 2016), and $12820.0 (Q4 2015), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn |
| 10 | Neogenomics | 1.46 Bn | 1.32 Bn | 80.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 182,744.00 |
| Dec 31, 2017 | 182,744.00 |
| Dec 31, 2016 | 33,083.00 |
| Dec 31, 2016 | 33,083.00 |
| Dec 31, 2015 | 12,820.00 |
| Dec 31, 2015 | 12,820.00 |
| Dec 31, 2014 | 18,125.00 |
| Dec 31, 2014 | 18,125.00 |
| Dec 31, 2013 | 32,000.00 |
| Dec 31, 2013 | 32,000.00 |
| Dec 31, 2012 | 50,000.00 |
| Dec 31, 2012 | 50,000.00 |